Clearside Biomedical stock falls after announcing strategic alternatives exploration By Investing.com
Clearside Biomedical stock falls after announcing strategic alternatives exploration…
3,722$
-7,41%
Echtzeit-Aktienkurs Clearside Biomedical Inc
Bid:
Ask:
Nachrichten zur Clearside Biomedical Inc Aktie
Clearside Biomedical to explore strategic alternatives amid cash concerns By Investing.com
Clearside Biomedical to explore strategic alternatives amid cash concerns…
Clearside Biomedical (CLSD) Upgraded to Buy: Heres What You Should Know
Clearside Biomedical (CLSD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of 8.33% and 785.93%, respectively, for the quarter ended March 2025. Do…
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Tops Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of 23.08% and 13.33%, respectively, for the quarter ended December 2024. Do…
Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema
ALPHARETTA, Ga., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical…
Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
ALPHARETTA, Ga., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
ALPHARETTA, Ga., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical, Inc. (CLSD) Suprachoroidal Space Drug Delivery (Transcript)
…
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical, Inc. (CLSD) Q1 2024 Earnings Call Transcript
…
Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
ALPHARETTA, Ga., April 02, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery…
Clearside Biomedical appoints new Chief Medical Officer By Investing.com
Clearside Biomedical appoints new Chief Medical Officer…
Earnings call: Clearside Biomedical reports on clinical trials and collaborations By Investing.com
Earnings call: Clearside Biomedical reports on clinical trials and collaborations…
Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript
…